Risk of reactivation of toxoplasmic retinitis following intraocular procedures without the use of prophylactic therapy

Background/aims Toxoplasmic retinochoroiditis is the commonest known cause of posterior uveitis worldwide and reactivation is unpredictable. Based on results from one study, the authors proposed that antitoxoplasmic therapy should be initiated as prophylaxis for intraocular surgery in patients with...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of ophthalmology Vol. 98; no. 9; pp. 1218 - 1220
Main Authors Heringer, Gustavo C, Oueghlani, Evelyne, Dell'Omo, Roberto, Curi, André L L, Oréfice, Fernando, Pavésio, Carlos E
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group LTD 01.09.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background/aims Toxoplasmic retinochoroiditis is the commonest known cause of posterior uveitis worldwide and reactivation is unpredictable. Based on results from one study, the authors proposed that antitoxoplasmic therapy should be initiated as prophylaxis for intraocular surgery in patients with toxoplasmic scars. The aim of this study is to analyse the risk of toxoplasmic retinochoroiditis reactivation following intraocular procedures. Methods Retrospective analysis of the medical records of a total of 69 patients who underwent intraocular surgery and presented with toxoplasmic retinochoroiditis scars. Results No patient received prophylactic antitoxoplasmic therapy. Reactivation following the surgical procedure occurred in four cases, with one at 3 months and the others respectively at 13, 14 and 17 months. Conclusions Our study shows that intraocular surgery did not result in a significant reactivation rate of toxoplasmic retinochoroiditis in the absence of preoperative prophylactic antitoxoplasmic therapy.
AbstractList Toxoplasmic retinochoroiditis is the commonest known cause of posterior uveitis worldwide and reactivation is unpredictable. Based on results from one study, the authors proposed that antitoxoplasmic therapy should be initiated as prophylaxis for intraocular surgery in patients with toxoplasmic scars. The aim of this study is to analyse the risk of toxoplasmic retinochoroiditis reactivation following intraocular procedures.BACKGROUND/AIMSToxoplasmic retinochoroiditis is the commonest known cause of posterior uveitis worldwide and reactivation is unpredictable. Based on results from one study, the authors proposed that antitoxoplasmic therapy should be initiated as prophylaxis for intraocular surgery in patients with toxoplasmic scars. The aim of this study is to analyse the risk of toxoplasmic retinochoroiditis reactivation following intraocular procedures.Retrospective analysis of the medical records of a total of 69 patients who underwent intraocular surgery and presented with toxoplasmic retinochoroiditis scars.METHODSRetrospective analysis of the medical records of a total of 69 patients who underwent intraocular surgery and presented with toxoplasmic retinochoroiditis scars.No patient received prophylactic antitoxoplasmic therapy. Reactivation following the surgical procedure occurred in four cases, with one at 3 months and the others respectively at 13, 14 and 17 months.RESULTSNo patient received prophylactic antitoxoplasmic therapy. Reactivation following the surgical procedure occurred in four cases, with one at 3 months and the others respectively at 13, 14 and 17 months.Our study shows that intraocular surgery did not result in a significant reactivation rate of toxoplasmic retinochoroiditis in the absence of preoperative prophylactic antitoxoplasmic therapy.CONCLUSIONSOur study shows that intraocular surgery did not result in a significant reactivation rate of toxoplasmic retinochoroiditis in the absence of preoperative prophylactic antitoxoplasmic therapy.
Background/aims Toxoplasmic retinochoroiditis is the commonest known cause of posterior uveitis worldwide and reactivation is unpredictable. Based on results from one study, the authors proposed that antitoxoplasmic therapy should be initiated as prophylaxis for intraocular surgery in patients with toxoplasmic scars. The aim of this study is to analyse the risk of toxoplasmic retinochoroiditis reactivation following intraocular procedures. Methods Retrospective analysis of the medical records of a total of 69 patients who underwent intraocular surgery and presented with toxoplasmic retinochoroiditis scars. Results No patient received prophylactic antitoxoplasmic therapy. Reactivation following the surgical procedure occurred in four cases, with one at 3 months and the others respectively at 13, 14 and 17 months. Conclusions Our study shows that intraocular surgery did not result in a significant reactivation rate of toxoplasmic retinochoroiditis in the absence of preoperative prophylactic antitoxoplasmic therapy.
Toxoplasmic retinochoroiditis is the commonest known cause of posterior uveitis worldwide and reactivation is unpredictable. Based on results from one study, the authors proposed that antitoxoplasmic therapy should be initiated as prophylaxis for intraocular surgery in patients with toxoplasmic scars. The aim of this study is to analyse the risk of toxoplasmic retinochoroiditis reactivation following intraocular procedures. Retrospective analysis of the medical records of a total of 69 patients who underwent intraocular surgery and presented with toxoplasmic retinochoroiditis scars. No patient received prophylactic antitoxoplasmic therapy. Reactivation following the surgical procedure occurred in four cases, with one at 3 months and the others respectively at 13, 14 and 17 months. Our study shows that intraocular surgery did not result in a significant reactivation rate of toxoplasmic retinochoroiditis in the absence of preoperative prophylactic antitoxoplasmic therapy.
Background/aimsToxoplasmic retinochoroiditis is the commonest known cause of posterior uveitis worldwide and reactivation is unpredictable. Based on results from one study, the authors proposed that antitoxoplasmic therapy should be initiated as prophylaxis for intraocular surgery in patients with toxoplasmic scars. The aim of this study is to analyse the risk of toxoplasmic retinochoroiditis reactivation following intraocular procedures.MethodsRetrospective analysis of the medical records of a total of 69 patients who underwent intraocular surgery and presented with toxoplasmic retinochoroiditis scars.ResultsNo patient received prophylactic antitoxoplasmic therapy. Reactivation following the surgical procedure occurred in four cases, with one at 3months and the others respectively at 13, 14 and 17months.ConclusionsOur study shows that intraocular surgery did not result in a significant reactivation rate of toxoplasmic retinochoroiditis in the absence of preoperative prophylactic antitoxoplasmic therapy.
Author Oueghlani, Evelyne
Heringer, Gustavo C
Curi, André L L
Pavésio, Carlos E
Oréfice, Fernando
Dell'Omo, Roberto
Author_xml – sequence: 1
  givenname: Gustavo C
  surname: Heringer
  fullname: Heringer, Gustavo C
  email: carlos.pavesio@moorfields.nhs.uk
  organization: Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
– sequence: 2
  givenname: Evelyne
  surname: Oueghlani
  fullname: Oueghlani, Evelyne
  email: carlos.pavesio@moorfields.nhs.uk
  organization: Moorfields Eye Hospital, London, UK
– sequence: 3
  givenname: Roberto
  surname: Dell'Omo
  fullname: Dell'Omo, Roberto
  email: carlos.pavesio@moorfields.nhs.uk
  organization: Moorfields Eye Hospital, London, UK
– sequence: 4
  givenname: André L L
  surname: Curi
  fullname: Curi, André L L
  email: carlos.pavesio@moorfields.nhs.uk
  organization: Instituto de Pesquisa Clínica Evandro Chagas—IPEC/Fiocruz, Rio de Janeiro, Brazil
– sequence: 5
  givenname: Fernando
  surname: Oréfice
  fullname: Oréfice, Fernando
  email: carlos.pavesio@moorfields.nhs.uk
  organization: Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
– sequence: 6
  givenname: Carlos E
  surname: Pavésio
  fullname: Pavésio, Carlos E
  email: carlos.pavesio@moorfields.nhs.uk
  organization: Moorfields Eye Hospital, London, UK
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24820044$$D View this record in MEDLINE/PubMed
BookMark eNqNkctu1TAQhi1URE8Lr4AisWETGF_iywYJVaUgVUJCsI4cxyE-OHGwnZbz9nU4BaFu6Go0M9_89sx_hk7mMFuEKgxvMKb8bbcPy5hH7afgawKY1hQYadQTtMOMy1IS6gTtAEDUGHN8is5S2peUcCyeoVPCJAFgbIduvrj0owpDFa022d3o7MK85Tn8CovXaXKm9LKbXXapGoL34dbN3ys356iDWb2O1RKDsf0abapuXR7Dmqs82mpNdlMq3WU8-E3ebPWol8Nz9HTQPtkX9_Ecfftw-fXiY339-erTxfvrumMEck2owsAG05FmgN5arQRwyqWV0g6cCqqU4VYQA6zrhegUaEmhh0FxrRnR9By9PuqWT_xcbcrt5JKx3uvZhjW1WIIU5YAY_o82DVOMYKYK-uoBug9rnMsiLRZCqkZxSgr18p5au8n27RLdpOOh_XP8AsgjYGJIKdrhL4Kh3Xxu__W53Xxujz6X0XcPRo3Lv70rrjj_GAF6FOim_eOfvQMrk8aB
CODEN BJOPAL
CitedBy_id crossref_primary_10_3109_09273948_2015_1051360
crossref_primary_10_4103_ijo_IJO_364_18
crossref_primary_10_3390_jcm10051090
crossref_primary_10_1136_bjophthalmol_2014_305869
crossref_primary_10_4103_sjopt_sjopt_147_21
crossref_primary_10_4103_ijo_IJO_740_17
crossref_primary_10_1080_09273948_2022_2026408
crossref_primary_10_1371_journal_pone_0283845
crossref_primary_10_1016_j_ajo_2018_11_013
crossref_primary_10_1097_ICU_0000000000000205
crossref_primary_10_1097_IAE_0000000000000973
crossref_primary_10_1080_09273948_2023_2203215
crossref_primary_10_1016_j_actatropica_2021_106180
Cites_doi 10.1001/archopht.1980.01020030317016
10.1016/j.ajo.2003.09.040
10.1097/00055735-200212000-00008
10.1055/s-2008-1045795
10.1016/S0161-6420(02)00990-9
10.1007/BF00220702
10.1016/j.ajo.2005.07.017
10.1016/0039-6257(90)90068-7
10.1016/S0002-9394(14)76693-0
10.1016/S0002-9394(02)01947-5
10.3109/09273949409057078
10.1076/ocii.8.4.285.6456
10.1016/S0161-6420(89)32898-3
10.1136/bjo.80.12.1099
10.1080/09273940591004232
10.1016/0002-9394(89)90260-2
10.1136/bjo.87.8.1010
10.1016/S0002-9394(02)01526-X
10.1016/S0140-6736(04)16412-X
10.1016/j.jcrs.2004.06.040
10.1016/S0161-6420(01)00845-4
10.1136/bjo.78.7.549
ContentType Journal Article
Copyright Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Copyright: 2014 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Copyright_xml – notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
– notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
– notice: Copyright: 2014 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
BTHHO
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
7TK
M7N
DOI 10.1136/bjophthalmol-2013-304259
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection (NC LIVE)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
BMJ Journals
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
Neurosciences Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
BMJ Journals
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
Neurosciences Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
DatabaseTitleList MEDLINE - Academic

MEDLINE
Neurosciences Abstracts
ProQuest One Academic Middle East (New)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1468-2079
EndPage 1220
ExternalDocumentID 4012569811
24820044
10_1136_bjophthalmol_2013_304259
bjophthalmol
Genre Research Support, Non-U.S. Gov't
Multicenter Study
Journal Article
GrantInformation_xml – fundername: Department of Health
GroupedDBID ---
-~X
.55
.GJ
.VT
0R~
18M
23N
2WC
354
39C
3O-
4.4
40O
53G
5GY
5RE
5VS
6J9
7X7
7~S
88E
8FI
8FJ
8R4
8R5
AAHLL
AAKAS
AAOJX
AAWJN
ABAAH
ABJNI
ABKDF
ABMQD
ABTFR
ABUWG
ABVAJ
ACCCW
ACGFO
ACGFS
ACGTL
ACHTP
ACMFJ
ACNCT
ACOAB
ACOFX
ACQSR
ACTZY
ADBBV
ADCEG
ADZCM
AENEX
AFKRA
AFWFF
AGQPQ
AHMBA
AHNKE
AHQMW
AJYBZ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
AZFZN
BAWUL
BENPR
BLJBA
BOMFT
BPHCQ
BTFSW
BTHHO
BVXVI
C1A
C45
CAG
CCPQU
COF
CS3
CXRWF
DIK
DU5
E3Z
EBS
EJD
F5P
FYUFA
H13
HAJ
HMCUK
HYE
HZ~
IAO
IEA
IHR
IOF
ITC
J5H
KQ8
L7B
M1P
N9A
NTWIH
NXWIF
O9-
OK1
OVD
P2P
PHGZT
PQQKQ
PROAC
PSQYO
Q2X
R53
RHI
RMJ
RPM
RV8
TEORI
TR2
UAW
UKHRP
UYXKK
V24
VM9
W8F
WH7
WOQ
X7M
XOL
YFH
YQY
ZGI
AAFWJ
AAYXX
ACQHZ
AERUA
CITATION
PHGZM
3V.
CGR
CUY
CVF
ECM
EIF
NPM
RHF
7XB
8FK
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
7TK
M7N
ID FETCH-LOGICAL-b420t-239104fcb25f0deea9706368e88ef637399c6e72c04bd77b90a830d0f96aa42a3
IEDL.DBID 7X7
ISSN 0007-1161
1468-2079
IngestDate Fri Jul 11 14:17:07 EDT 2025
Fri Jul 11 08:05:27 EDT 2025
Fri Jul 25 02:50:30 EDT 2025
Thu Jan 02 22:15:48 EST 2025
Thu Apr 24 23:08:22 EDT 2025
Tue Jul 01 01:47:59 EDT 2025
Thu Apr 24 23:02:35 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Infection
Inflammation
Language English
License Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b420t-239104fcb25f0deea9706368e88ef637399c6e72c04bd77b90a830d0f96aa42a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 24820044
PQID 1778959632
PQPubID 2041039
PageCount 3
ParticipantIDs proquest_miscellaneous_1808720110
proquest_miscellaneous_1554942149
proquest_journals_1778959632
pubmed_primary_24820044
crossref_primary_10_1136_bjophthalmol_2013_304259
crossref_citationtrail_10_1136_bjophthalmol_2013_304259
bmj_primary_10_1136_bjophthalmol_2013_304259
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-09-01
PublicationDateYYYYMMDD 2014-09-01
PublicationDate_xml – month: 09
  year: 2014
  text: 2014-09-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle British journal of ophthalmology
PublicationTitleAlternate Br J Ophthalmol
PublicationYear 2014
Publisher BMJ Publishing Group LTD
Publisher_xml – name: BMJ Publishing Group LTD
References Holland 2003; 136
Nussenblatt, Mittal, Fuhrman 1989; 107
Fitzgerald 1980; 98
Verbraeken 1996; 234
Montoya, Liesenfeld 2004; 363
Becker, Davis 2005; 140
Androudi, Ahmed, Fiore 2005; 31
Barton, Hall, Rosen 1994; 2
Le Quoy, Chouquet, Marchetti 1999; 22
Adan, Mateo, Wolley-Dod 2003; 135
Pavésio, Lightman 1996; 80
Foster, Fong, Singh 1989; 96
Heiligenhaus, Bornfeld, Foerster 1994; 78
Hooper, Rao, Smith 1990; 35
Holland 2004; 137
Nolle, Eckardt 1993; 2
Smith, Cunningham 2002; 13
Baarsma, Luyendjik, Kijlstra 1991; 112
Bosch-Driessen, Plaisier, Stilma 2002; 109
Bosch-Driessen, Berendschot, Ongkosuwito 2002; 109
Bovey, Herbort 2000; 8
Holland, Lewis 2002; 134
Sonoda, Enaida, Ueno 2003; 87
Ahn, Chung, Yu 2005; 13
Bovey, Gonvers, Herbort 1992; 200
Verbraeken (key-10.1136/bjophthalmol-2013-304259-13) 1996; 234
Le Quoy (key-10.1136/bjophthalmol-2013-304259-24) 1999; 22
Holland (key-10.1136/bjophthalmol-2013-304259-22) 2004; 137
Nolle (key-10.1136/bjophthalmol-2013-304259-15) 1993; 2
Baarsma (key-10.1136/bjophthalmol-2013-304259-21) 1991; 112
Holland (key-10.1136/bjophthalmol-2013-304259-1) 2003; 136
Pavésio (key-10.1136/bjophthalmol-2013-304259-4) 1996; 80
Heiligenhaus (key-10.1136/bjophthalmol-2013-304259-14) 1994; 78
Adan (key-10.1136/bjophthalmol-2013-304259-23) 2003; 135
Holland (key-10.1136/bjophthalmol-2013-304259-3) 2002; 134
Sonoda (key-10.1136/bjophthalmol-2013-304259-11) 2003; 87
Becker (key-10.1136/bjophthalmol-2013-304259-10) 2005; 140
Fitzgerald (key-10.1136/bjophthalmol-2013-304259-26) 1980; 98
Foster (key-10.1136/bjophthalmol-2013-304259-17) 1989; 96
Nussenblatt (key-10.1136/bjophthalmol-2013-304259-5) 1989; 107
Montoya (key-10.1136/bjophthalmol-2013-304259-20) 2004; 363
Bovey (key-10.1136/bjophthalmol-2013-304259-25) 1992; 200
Ahn (key-10.1136/bjophthalmol-2013-304259-8) 2005; 13
Bovey (key-10.1136/bjophthalmol-2013-304259-12) 2000; 8
Bosch-Driessen (key-10.1136/bjophthalmol-2013-304259-6) 2002; 109
Barton (key-10.1136/bjophthalmol-2013-304259-19) 1994; 2
Holland (key-10.1136/bjophthalmol-2013-304259-16) 1996
Smith (key-10.1136/bjophthalmol-2013-304259-2) 2002; 13
Hooper (key-10.1136/bjophthalmol-2013-304259-18) 1990; 35
Androudi (key-10.1136/bjophthalmol-2013-304259-9) 2005; 31
Bosch-Driessen (key-10.1136/bjophthalmol-2013-304259-7) 2002; 109
References_xml – volume: 136
  start-page: 973
  year: 2003
  article-title: Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of the disease
  publication-title: Am J Ophthalmol
– volume: 31
  start-page: 472
  year: 2005
  article-title: Combined pars plana vitrectomy and phacoemulsification to restore visual acuity in patients with chronic uveitis
  publication-title: J Cataract Refract Surg
– volume: 87
  start-page: 1010
  year: 2003
  article-title: Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study
  publication-title: Br J Ophthalmol
– volume: 13
  start-page: 387
  year: 2002
  article-title: Atypical presentations of ocular toxoplasmosis
  publication-title: Curr Opin Ophthalmol
– volume: 109
  start-page: 41
  year: 2002
  article-title: Reactivations of ocular toxoplasmosis after cataract extraction
  publication-title: Ophthalmology
– volume: 8
  start-page: 285
  year: 2000
  article-title: Vitrectomy in the management of uveitis
  publication-title: Ocul Immunol Inflamm
– volume: 112
  start-page: 147
  year: 1991
  article-title: Analysis of local antibody production in the vitreous humor of patients with severe uveitis
  publication-title: Am J Ophthalmol
– volume: 35
  start-page: 120
  year: 1990
  article-title: Cataract extraction in uveitis patients
  publication-title: Survey of Ophthalmology
– volume: 135
  start-page: 386
  year: 2003
  article-title: Surgery for subfoveal choroidal neovascularization in toxoplasmic retinochoroiditis
  publication-title: Am J Ophthalmol
– volume: 140
  start-page: 1096
  year: 2005
  article-title: Vitrectomy in the treatment of uveitis
  publication-title: Am J Ophthalmol
– volume: 363
  start-page: 1965
  year: 2004
  article-title: Toxoplasmosis
  publication-title: Lancet
– volume: 2
  start-page: 14
  year: 1993
  article-title: Vitrectomy in multifocal chorioretinitis
  publication-title: Ger J Ophthalmol
– volume: 234
  start-page: 288
  year: 1996
  article-title: Therapeutic pars plana vitrectomy for chronic uveitis: a retrospective study of the long-term results
  publication-title: Graefes Arch Clin Exp Ophthalmol
– volume: 96
  start-page: 281
  year: 1989
  article-title: Cataract surgery and intraocular lens implantation in patients with uveitis
  publication-title: Ophthalmology
– volume: 22
  start-page: 864
  year: 1999
  article-title: Surgery of retrofoveal neovascularization in inflammatory diseases: indications and results. A retrospective study
  publication-title: J Fr Ophtalmol
– volume: 13
  start-page: 447
  year: 2005
  article-title: Vitrectomy for persistent panuveitis in Behcet's disease
  publication-title: Ocul Immunol Inflamm
– volume: 107
  start-page: 632
  year: 1989
  article-title: Lymphocyte proliferative responses of patients with ocular toxoplasmosis to parasite and retinal antigens
  publication-title: Am J Ophthalmol
– volume: 137
  start-page: 1
  year: 2004
  article-title: Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management
  publication-title: Am J Ophthalmol
– volume: 2
  start-page: 207
  year: 1994
  article-title: Systemic steroid prophylaxis for cataract surgery in patients with posterior uveitis
  publication-title: Ocul Immunol Inflamm
– volume: 98
  start-page: 321
  year: 1980
  article-title: Pars plana vitrectomy for vitreous opacity secondary to presumed toxoplasmosis
  publication-title: Arch Ophthalmol
– volume: 134
  start-page: 102
  year: 2002
  article-title: An update on current practices in the management of ocular toxoplasmosis
  publication-title: Am J Ophthalmol
– volume: 80
  start-page: 1099
  year: 1996
  article-title: Toxoplasma gondii and ocular toxoplasmosis: pathogenesis
  publication-title: Br J Ophthalmol
– volume: 109
  start-page: 869
  year: 2002
  article-title: Ocular toxoplasmosis: clinical features and prognosis of 154 patients
  publication-title: Ophthalmology
– volume: 200
  start-page: 464
  year: 1992
  article-title: Pars plana vitrectomy for uveitis
  publication-title: Klin Monatsbl Augenheilkd
– volume: 78
  start-page: 549
  year: 1994
  article-title: Long-term results of pars plana vitrectomy in the management of complicated uveitis
  publication-title: Br J Ophthalmol
– volume: 98
  start-page: 321
  year: 1980
  ident: key-10.1136/bjophthalmol-2013-304259-26
  article-title: Pars plana vitrectomy for vitreous opacity secondary to presumed toxoplasmosis
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1980.01020030317016
– volume: 136
  start-page: 973
  year: 2003
  ident: key-10.1136/bjophthalmol-2013-304259-1
  article-title: Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of the disease
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2003.09.040
– volume: 13
  start-page: 387
  year: 2002
  ident: key-10.1136/bjophthalmol-2013-304259-2
  article-title: Atypical presentations of ocular toxoplasmosis
  publication-title: Curr Opin Ophthalmol
  doi: 10.1097/00055735-200212000-00008
– volume: 200
  start-page: 464
  year: 1992
  ident: key-10.1136/bjophthalmol-2013-304259-25
  article-title: Pars plana vitrectomy for uveitis
  publication-title: Klin Monatsbl Augenheilkd
  doi: 10.1055/s-2008-1045795
– volume: 109
  start-page: 869
  year: 2002
  ident: key-10.1136/bjophthalmol-2013-304259-6
  article-title: Ocular toxoplasmosis: clinical features and prognosis of 154 patients
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(02)00990-9
– volume: 234
  start-page: 288
  year: 1996
  ident: key-10.1136/bjophthalmol-2013-304259-13
  article-title: Therapeutic pars plana vitrectomy for chronic uveitis: a retrospective study of the long-term results
  publication-title: Graefes Arch Clin Exp Ophthalmol
  doi: 10.1007/BF00220702
– volume: 140
  start-page: 1096
  year: 2005
  ident: key-10.1136/bjophthalmol-2013-304259-10
  article-title: Vitrectomy in the treatment of uveitis
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2005.07.017
– volume: 35
  start-page: 120
  year: 1990
  ident: key-10.1136/bjophthalmol-2013-304259-18
  article-title: Cataract extraction in uveitis patients
  publication-title: Survey of Ophthalmology
  doi: 10.1016/0039-6257(90)90068-7
– volume: 112
  start-page: 147
  year: 1991
  ident: key-10.1136/bjophthalmol-2013-304259-21
  article-title: Analysis of local antibody production in the vitreous humor of patients with severe uveitis
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(14)76693-0
– volume: 135
  start-page: 386
  year: 2003
  ident: key-10.1136/bjophthalmol-2013-304259-23
  article-title: Surgery for subfoveal choroidal neovascularization in toxoplasmic retinochoroiditis
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(02)01947-5
– start-page: 1183
  volume-title: Ocular infection and immunity
  year: 1996
  ident: key-10.1136/bjophthalmol-2013-304259-16
  article-title: Toxoplasmosis
– volume: 2
  start-page: 207
  year: 1994
  ident: key-10.1136/bjophthalmol-2013-304259-19
  article-title: Systemic steroid prophylaxis for cataract surgery in patients with posterior uveitis
  publication-title: Ocul Immunol Inflamm
  doi: 10.3109/09273949409057078
– volume: 137
  start-page: 1
  year: 2004
  ident: key-10.1136/bjophthalmol-2013-304259-22
  article-title: Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management
  publication-title: Am J Ophthalmol
– volume: 8
  start-page: 285
  year: 2000
  ident: key-10.1136/bjophthalmol-2013-304259-12
  article-title: Vitrectomy in the management of uveitis
  publication-title: Ocul Immunol Inflamm
  doi: 10.1076/ocii.8.4.285.6456
– volume: 96
  start-page: 281
  year: 1989
  ident: key-10.1136/bjophthalmol-2013-304259-17
  article-title: Cataract surgery and intraocular lens implantation in patients with uveitis
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(89)32898-3
– volume: 80
  start-page: 1099
  year: 1996
  ident: key-10.1136/bjophthalmol-2013-304259-4
  article-title: Toxoplasma gondii and ocular toxoplasmosis: pathogenesis
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.80.12.1099
– volume: 13
  start-page: 447
  year: 2005
  ident: key-10.1136/bjophthalmol-2013-304259-8
  article-title: Vitrectomy for persistent panuveitis in Behcet's disease
  publication-title: Ocul Immunol Inflamm
  doi: 10.1080/09273940591004232
– volume: 107
  start-page: 632
  year: 1989
  ident: key-10.1136/bjophthalmol-2013-304259-5
  article-title: Lymphocyte proliferative responses of patients with ocular toxoplasmosis to parasite and retinal antigens
  publication-title: Am J Ophthalmol
  doi: 10.1016/0002-9394(89)90260-2
– volume: 87
  start-page: 1010
  year: 2003
  ident: key-10.1136/bjophthalmol-2013-304259-11
  article-title: Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.87.8.1010
– volume: 22
  start-page: 864
  year: 1999
  ident: key-10.1136/bjophthalmol-2013-304259-24
  article-title: Surgery of retrofoveal neovascularization in inflammatory diseases: indications and results. A retrospective study
  publication-title: J Fr Ophtalmol
– volume: 134
  start-page: 102
  year: 2002
  ident: key-10.1136/bjophthalmol-2013-304259-3
  article-title: An update on current practices in the management of ocular toxoplasmosis
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(02)01526-X
– volume: 2
  start-page: 14
  year: 1993
  ident: key-10.1136/bjophthalmol-2013-304259-15
  article-title: Vitrectomy in multifocal chorioretinitis
  publication-title: Ger J Ophthalmol
– volume: 363
  start-page: 1965
  year: 2004
  ident: key-10.1136/bjophthalmol-2013-304259-20
  article-title: Toxoplasmosis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(04)16412-X
– volume: 31
  start-page: 472
  year: 2005
  ident: key-10.1136/bjophthalmol-2013-304259-9
  article-title: Combined pars plana vitrectomy and phacoemulsification to restore visual acuity in patients with chronic uveitis
  publication-title: J Cataract Refract Surg
  doi: 10.1016/j.jcrs.2004.06.040
– volume: 109
  start-page: 41
  year: 2002
  ident: key-10.1136/bjophthalmol-2013-304259-7
  article-title: Reactivations of ocular toxoplasmosis after cataract extraction
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(01)00845-4
– volume: 78
  start-page: 549
  year: 1994
  ident: key-10.1136/bjophthalmol-2013-304259-14
  article-title: Long-term results of pars plana vitrectomy in the management of complicated uveitis
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.78.7.549
SSID ssj0002617
Score 2.1864505
Snippet Background/aims Toxoplasmic retinochoroiditis is the commonest known cause of posterior uveitis worldwide and reactivation is unpredictable. Based on results...
Toxoplasmic retinochoroiditis is the commonest known cause of posterior uveitis worldwide and reactivation is unpredictable. Based on results from one study,...
Background/aimsToxoplasmic retinochoroiditis is the commonest known cause of posterior uveitis worldwide and reactivation is unpredictable. Based on results...
SourceID proquest
pubmed
crossref
bmj
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1218
SubjectTerms Adolescent
Adult
Aged
Chorioretinitis - etiology
Chorioretinitis - prevention & control
Coccidiostats - administration & dosage
Female
Humans
Male
Middle Aged
Phacoemulsification
Recurrence
Retrospective Studies
Risk Assessment - methods
Surgical Wound Infection - etiology
Surgical Wound Infection - prevention & control
Toxoplasmosis, Ocular - etiology
Toxoplasmosis, Ocular - prevention & control
Vitrectomy
Young Adult
Title Risk of reactivation of toxoplasmic retinitis following intraocular procedures without the use of prophylactic therapy
URI http://bjo.bmj.com/content/98/9/1218.full
https://www.ncbi.nlm.nih.gov/pubmed/24820044
https://www.proquest.com/docview/1778959632
https://www.proquest.com/docview/1554942149
https://www.proquest.com/docview/1808720110
Volume 98
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9wwEBZNAqWXkr63SYMKPVZElrR6nEJaEkIhoYQG9mYkWyKb7K62td3Hv-9ItrftoSFHo4fFaDTzzWg0g9A7HrivK64IdcETkH6KGGkdEd5QAZacs_ktzPmFPLsSn2bT2eBwa4awylEmZkFdxyr5yA8LpbSZAruwo_VXkqpGpdvVoYTGFtpJqcsSV6vZxuDK2cZ7-KtIAdBmjOTh8tDdxPV1e20Xy7gATik4SXZ9yli65ZY3_yqp_yDPrIFOd9HjATri436vn6AHfvUUPTwfLsefoe-X8-YWx4ABB1Zj1bL03cafcQ0oeTmvcHq0mOKFGhyAA-IP0Fx4nhy8MQek4qzQ6g6McJxctLFrMUBE3DU-zQStsC2L_LAK90-3fj1HV6cnXz6ekaGsAnGC0ZYwDhBBhMqxaaC199YowClSe619kFwBZKmkV6yiwtVKOUOt5rSmATbRCmb5C7S9iiv_CmFrhAWIKZ0IRsA0ztSWGR2mSkgnCzdB74Ga5bpPnFFmg4PL8m_il4n4ZU_8CVIj2ctqSFGeKmUs7jGy2Iy8_9_2x50th4PblH_YbILebprhyKV7FLvysYM-AMGMYGBb3tFHU60yuJqglz3XbBbGhE6ySby-ewF76BFMIPqAtn203X7r_BtAQK07yGx-gHY-nFx8vvwNUcoIIA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwELXaIgEXxDcLBYwEN6w6tteODwghoNrSbg-olfYW7MRWt-yuFzah9E_xGxk7yQIHql56jGI7yeR55o0940HoJffcVSVXhFrvCGg_RbQ0lginqQBPzpqUCzM-lKNj8WkynGygX30uTAyr7HViUtRVKOMa-U6mVK6HABf2dvmNxKpRcXe1L6HRwmLfnZ-By7Z6s_cB_u8rxnY_Hr0fka6qALGC0ZowDhZS-NKyoaeVc0YrMNMyd3nuvOQKLHYpnWIlFbZSympqck4r6uEbjGCGw7ib6BoYXhqdPTVZO3jpdPOWbiuSAZXqI4e43LGnYXlSn5jZPMwAmRkncR0hnpC6aeen_xrF_zDdZPF2b6NbHVXF71ps3UEbbnEXXR93m_H30I_P09VXHDwG3ln2VdLidR1-hiWw8vm0xDFJMsYnrbAHxIUzsJR4GheUQwqAxcmAVg04_TguCYemxkBJcbNycSS4CzCYpUQu3KaKnd9Hx1ci8AdoaxEW7hHCRgsDlFZa4bWAYayuDNO5HyohrczsAL0GaRbL9qCOIjk4XBZ_C7-Iwi9a4Q-Q6sVelN2R6LEyx-wSPbN1z8s_bbv_s0WnKFbFH1gP0Iv1bZjicd_GLFxooA1QPi0Y-LIXtMlprhKZG6CHLWrWL8ZEHnWheHzxCzxHN0ZH44PiYO9w_wm6CYOJNphuG23V3xv3FNhXbZ8lyGP05arn2G-2Y0LP
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB61W6nignizUMBIcCPaxPba8QEhoF21lK6qikq9BTux1S2766XJUvrX-HWM81jgQNVLj5FjJ5l8nvnGnvEAvGKO2SJnMoqNsxFqPxkpoU3ErYo5enJG17kwB2Oxe8w_nQxP1uBXlwsTwio7nVgr6sLnYY18kEiZqiHChQ5cGxZxuD16t_gehQpSYae1K6fRQGTfXl6g-1a-3dvGf_2a0tHOl4-7UVthIDKcxlVEGVpL7nJDhy4urNVKoskWqU1T6wSTaL1zYSXNY24KKY2KdcriInb4PZpTzXDcddiQwSvqwcaHnfHh0coOhLPOG_ItowSJVRdHxMTAnPnFaXWqpzM_RZwmLAqrCuG81HUzO_vXRP6H99b2b3QHbrfElbxvkHYX1uz8HmwetFvz9-HH0aT8RrwjyELzrmZauK78T79Ajj6b5CSkTIZopZI4xJ-_QLtJJmF52dfhsKQ2p8Xy3JYkLBD7ZUWQoJJlacNI2IqgmNZpXaRJHLt8AMc3IvKH0Jv7uX0MRCuukeAKw53iOIxRhaYqdUPJhRGJ6cMblGa2aI7tyGp3h4nsb-FnQfhZI_w-yE7sWd4ekB7qdEyv0TNZ9bz-07a6P5u1aqPM_oC8Dy9XzTjhwy6Onlu_xHuQACpO0bO94p40TmVN7frwqEHN6sUoT4Nm5E-ufoEXsInzK_u8N95_CrdwLN5E1m1Brzpf2mdIxSrzvMU8ga83Pc1-Ay75SGo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Risk+of+reactivation+of+toxoplasmic+retinitis+following+intraocular+procedures+without+the+use+of+prophylactic+therapy&rft.jtitle=British+journal+of+ophthalmology&rft.au=Heringer%2C+Gustavo+C&rft.au=Oueghlani%2C+Evelyne&rft.au=Dell%27Omo%2C+Roberto&rft.au=Curi%2C+Andr%C3%A9+L+L&rft.date=2014-09-01&rft.eissn=1468-2079&rft.volume=98&rft.issue=9&rft.spage=1218&rft_id=info:doi/10.1136%2Fbjophthalmol-2013-304259&rft_id=info%3Apmid%2F24820044&rft.externalDocID=24820044
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1161&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1161&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1161&client=summon